Assays Under Development -AIT Bioscience

Assays Under Development

AITB has developed and validated hundreds of assays for small molecules, peptide drugs, and antibody-based therapeutics. The list of AITB-proprietary assays and the assays under development, reported below, are only a partial list of our analytical capabilities in a variety of matrices for preclinical and clinical studies. Given our extensive bioanalytical experience, it’s likely we have encountered compounds that possess similar chemical activity to your molecule.

 

Integrating assay development experience, industry leading quality systems, and efficient lab operations, we can deliver QA data weeks ahead of industry standards. We work collaboratively with clinical and Tox sites to ensure studies flow smoothly.

 

Compound:

  • Analysis of Mitomycin C
  • Anti-Insulin Antibodies
  • Anti-PEG Antibody
  • Benzoic Acid and Hippuric Acid
  • Bezafibrate
  • Bupivicaine
  • C-Peptide by ELISA
  • Caffeic Acid Phenethyl Ester and Caffeic Acid
  • Clobetasol 17-Propionate
  • Cocaine and metabolites benzoylecgonine (BE) and ecgonine methyl ester (EME)
  • Cytarabine
  • D-(-)-Ribose
  • D-Serine
  • Deslorelin
  • Dihydroergotamine
  • Glucagon
  • Glucagon by ECL-ELISA
  • Glucose
  • Hydralazine
  • IgG2 Antibodies by HTRF
  • IL-12
  • IL-17  by ELISA
  • Infliximab by ELISA
  • Insulin
  • Insulin Lispro
  • Ketoprofen
  • Lacosamide
  • Levetiracetam
  • Levodopa and Carbidopa
  • Liraglutide
  • Morphine and Pseudomorphine
  • N-Acetyl-L-Cysteine
  • Oxytocin
  • Oxytocin
  • Paclitaxel
  • Plovamer
  • Polymyxin
  • Rapamycin and Secorapamycin
  • Testosterone
  • Tonabersat
  • Triptorelin
  • Valproic Acid
  • ZanamivirBezafibrate